XLXingRong Lu

XingRong Lu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


XingRong Lu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Guoxian Guan

    Department of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China

    4 shared publications
  • Zhen Pan

    Department of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University

    4 shared publications
  • Bin Chen

    Department of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University

    3 shared publications
  • Jinfu Zhuang

    Department of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University

    3 shared publications
  • Tengyi Peng

    Department of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University

    3 shared publications
  • Xing Liu

    Department of Colorectal Surgery, The First Affiliated Hospital of Fujian Medical University

    3 shared publications

Latest Publications

  • Open Access

    Metabolic dynamic score and machine learning: a novel approach to predicting pathological complete response in rectal cancer after neoadjuvant chemoradiotherapy

    by Tengyi Peng, Qiqi Zhang, Xingrong Lai, Zhen Pan, Bin Chen, Zhicheng Zhuang, Shaoqing Zheng, Xing Liu, Jinfu Zhuang, XingRong Lu, et al.

    Background: This study developed a scoring system based on the dynamic changes in biochemical indicators in advance of and subsequent to neoadjuvant chemoradiotherapy (NCRT) in individuals with locally advanced rectal cancer (LARC). The scoring system, combined with other clinical features, was used to develop a machine learning (ML) model aimed at predicting a pathological complete response (pCR). Methods: A review of earlier data was performed on the data of 1300 patients with LARC treated at Center1 and Center 2. To determine factors linked to pCR and create the scoring system, uni and multivariate logistic regression analyses were conducted. The development of predictive models involved the use of 10 ML methods, while model performance was evaluated using the area under the receiver operating characteristic curve (AUC), area under the precision-recall curve (AUPRC), decision curve analysis, and calibration curves. Additionally, SHapley Additive exPlanations values were applied to enhance model interpretability. Results: Multivariate analysis identified the MDS, tumor size, clinical T stage, and clinical N stage as independent predictors, which were incorporated into the ML models. Among the 10 ML models, the XGBoost model demonstrated the best and most generalizable predictive performance (training set: AUC = 0.93, AUPRC = 0.732; external validation set: AUC = 0.92, AUPRC = 0.779) and was selected as the optimal model. Conclusion: This study analyzed changes in biochemical indicators pre- versus post-NCRT and developed a promising MDS. By leveraging ML predictive models to estimate pCR, this approach may serve as a convenient tool to support the clinical decision-making process pending further prospective validation.

  • Open Access

    Interpretable AI-driven prediction of early postoperative recurrence in locally advanced rectal cancer using the Systemic Inflammatory–Nutritional Index (SINTI): A multi-center study and clinical web tool

    by Zhen Pan, Tengyi Peng, Ye Wang, Bin Chen, Zhicheng Zhuang, XingRong Lu, Shoufeng Li, Guoxian Guan

    Background Patients with locally advanced rectal cancer (LARC) who undergo neoadjuvant chemoradiotherapy (NCRT) and subsequently experience early recurrence (ER) within two years post-surgery tend to have unfavorable prognoses. Therefore, the accurate prediction of ER in LARC is of paramount importance. Purpose This study aimed to develop and validate an explainable artificial intelligence (AI) model, based on the systemic inflammation–nutritional tumor biomarker index (SINTI) derived from routine blood biomarkers, to predict ER in patients with LARC. Methods We conducted a multicenter retrospective analysis involving two distinct patient cohorts: Cohort A (n = 715; from February 2011 to September 2017) and Cohort B (n = 224; spanning June 2020 to June 2023). Feature selection was executed utilizing the least absolute shrinkage and selection operator (LASSO) regularization to construct SINTI, effectively addressing multicollinearity. Predictive modeling incorporated ten different machine learning architectures, with hyperparameter optimization achieved through a randomized search complemented by nested tenfold cross-validation. Model performance was thoroughly evaluated using multiple metrics, including the area under the receiver operating characteristic curve (AUC), area under the precision-recall curve (AUPRC), clinical utility curves, and calibration plots. The interpretability of the model was enhanced through SHAP value analysis, followed by its deployment as a clinical decision support web application. Results The study included 715 patients from Center One and 224 from Center Two, identifying six key biomarkers as the core components of the SINTI model. Multivariable analysis confirmed that SINTI, clinical N stage, clinical T stage, and tumor size are independent predictors of early recurrence. The XGBoost algorithm exhibited robust discrimination during training cohort cross-validation, achieving a mean AUC of 0.860 (SD ± 0.021) and demonstrating consistent performance across validation datasets, with an internal AUC of 0.842 and an external AUC of 0.840. SHAP value interpretation revealed monotonic relationships between predictor variables and recurrence risk, with SINTI accounting for 36.1% of the total predictive weight. For clinical implementation, we deployed the optimized model as a web-based decision support tool, which can be accessed at https://p7toqbsdfbhlahdrugj4ra.streamlit.app/. Conclusion This interpretable AI framework demonstrates the potential to bridge data-driven modeling and clinical decision support, offering a transparent, potentially deployable solution for post-NCRT recurrence risk prediction following further prospective validation.

  • Open Access

    Development and validation of machine-learning model based on dynamic tumor markers in predicting pathological complete response after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a multicenter cohort study

    by Bin Chen, Tengyi Peng, Zhen Pan, Shoufeng Li, Ye Wang, Shaoqing Zheng, Jinfu Zhuang, Xing Liu, Xingrong Lu, Changqing Zeng, et al.

    Objective In this study, we constructed a new pCR predictor based on dynamic tumor marker changes before and after NCRT, the dynamic tumor marker score (DTMS), and combined it with other clinicopathological features to build a machine-learning model. Methods In this retrospective study of patients with LARC between September 2010 and October 2017 at The First Affiliated Hospital of Fujian Medical University (FJMUFAH), Fujian Medical University Union Hospital (FJMUUH), and Fujian Provincial Hospital (FJPH), the DTMS predictor was constructed using logistic regression. Factors associated with pCR were screened using single-factor and multifactorial logistic regression, and 10 machine-learning algorithms were used to construct a pCR prediction model. Additionally, various metrics, including the area under the receiver operating characteristic curve (AUC), area under the precision-recall curve (AUPRC), decision curve analysis, and calibration curves, were obtained to validate the model performance and verified using an external validation set. Finally, SHapley Additive exPlanations (SHAP) values were used to interpret the predictive model. Moreover, we developed a website to facilitate the use of prediction modeling. Results After analyzing the data of 892 patients with LARC from FJMUFAH, DTMS, tumor size, N stage, and tumor distance from the anal verge were identified as independent predictive factors for pCR using univariate and multivariate regression analyses. The “extreme gradient boosting” (XGB) model displayed the best performance in the training set, with a mean AUC value of 0.86, an AUPRC value of 0.732, and SHAP values utilized in the analysis. In the two external validation sets, the model yielded AUC values of 0.80 and 0.82, along with corresponding AUPRC values of 0.519 and 0.593, respectively, which were the highest among all ten evaluated models, incorporating the use of SHAP values in the analysis. The model maintained superior predictive efficacy in the external validation cohorts (FJMUUH and FJPH). Conclusions As a novel marker based on dynamic changes in CEA and CA19-9 levels, DTMS effectively predicted pCR within the XGB model, providing clinicians with a practical tool for treatment decision-making regarding LARC.